Adcock Ingram Holdings Ltd. is a pharmaceutical company, which engages in the manufacture, marketing, and distribution of healthcare products to both private and public sectors of the market. The company is headquartered in Midrand, Gauteng. The company went IPO on 2008-08-25. The firm manufactures, markets, and distributes a range of healthcare and consumer products, and is a supplier to the private sector. Its segments include Consumer, Over the Counter (OTC), Prescription, Hospital, and Other. The Consumer segment is engaged mainly in the fast-moving consumer goods (FMCG) space. The OTC segment focuses on brands sold predominantly in pharmacies. The Prescription segment markets products prescribed by medical practitioners, and specialized instruments and surgical products. Its Hospital segment supplies hospital and critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. The Other segment includes shared services and other support services, including regulatory services in India, as well as the investment in the joint venture and cash and bank overdraft balances, which are managed on a central basis in Southern Africa.
Follow-Up Questions
Adcock Ingram Holdings Ltd 的 CEO 是誰?
Mr. Andrew Hall 是 Adcock Ingram Holdings Ltd 的 Chief Executive Officer,自 2007 加入公司。
AIHLF 股票的價格表現如何?
AIHLF 的當前價格為 $0,在上個交易日 decreased 了 0%。
Adcock Ingram Holdings Ltd 的主要業務主題或行業是什麼?
Adcock Ingram Holdings Ltd 屬於 Pharmaceuticals 行業,該板塊是 Health Care